戻る
Jiangsu Recbio Technology Co., Ltd. (02179.HK)価格
02179.HK 株価推移チャート
RECBIO-B (02179.HK)
Jiangsu Recbio Technology Co., Ltd.
HK$5.7
3.63%
$0.2
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
02179.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Jiangsu Recbio Technology Co., Ltd. 02179.HKの前四半期の収益はどうでしたか？
Jiangsu Recbio Technology Co., Ltd.の収益見積もりはいくらですか？
Jiangsu Recbio Technology Co., Ltd.の収益品質スコアはどれくらいですか？
Jiangsu Recbio Technology Co., Ltd.はいつ収益を報告しますか？
Jiangsu Recbio Technology Co., Ltd.の予想収益はいくらですか？
Jiangsu Recbio Technology Co., Ltd.は収益予想を上回りましたか？
主要データ
前終値
$5.48
始値
$5.5
当日レンジ
$5.48 - $5.7
52週レンジ
$3.4 - $9.8
取引高
11.5K
平均取引高
44.4K
1株当たり利益(TTM)
-1.51
配当利回り
--
時価総額
$1.8B
RECBIO-Bとは何ですか？
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.